See also this year's filing and all EDGAR filings for this company.
PDF Report 0001351288_2019_GW_PHARMACEUTICALS_PLC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001351288')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001351288, GW PHARMACEUTICALS PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 390,711,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,959,000 |
| 2 | PropertyPlantAndEquipmentNet | 82,381,000 |
| 3 | remainder_Assets | 10,484,000 |
| 4 | LiabilitiesCurrent | 58,669,000 |
| 5 | LiabilitiesNoncurrent | 16,707,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 5,986,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 141,818,000 |
| 9 | ResearchAndDevelopmentExpense | 153,736,000 |
| 10 | remainder_Expenses | 5,046,000 |
| 11 | remainder_Revenues | 12,737,000 |
| 12 | remainder_NetIncome | -1,318,000 |
| 13 | remainder_ComprehensiveNetIncome | -676,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 490,535,000 |
| 1 | Liabilities | 75,376,000 |
| 2 | Expenses | 306,586,000 |
| 3 | Revenues | 12,737,000 |
| 4 | StockholdersEquity | 415,159,000 |
| 5 | NetIncome | -295,167,000 |
| 6 | ComprehensiveNetIncome | -295,505,000 |
| 7 | BaseVar | 443,614,000 |
| 8 | EconomicCapitalRatio | 1.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
